Jim McVeigh

3.7k total citations
100 papers, 2.4k citations indexed

About

Jim McVeigh is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Sociology and Political Science. According to data from OpenAlex, Jim McVeigh has authored 100 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Endocrinology, Diabetes and Metabolism, 34 papers in Epidemiology and 20 papers in Sociology and Political Science. Recurrent topics in Jim McVeigh's work include Hormonal and reproductive studies (35 papers), HIV, Drug Use, Sexual Risk (26 papers) and Doping in Sports (17 papers). Jim McVeigh is often cited by papers focused on Hormonal and reproductive studies (35 papers), HIV, Drug Use, Sexual Risk (26 papers) and Doping in Sports (17 papers). Jim McVeigh collaborates with scholars based in United Kingdom, Australia and Ireland. Jim McVeigh's co-authors include Mark A Bellis, Andreas Kimergård, Caryl Beynon, Geoff Bates, Lisa Jones, Marie Claire Van Hout, Michael Evans‐Brown, Harry Sumnall, Vivian Hope and Andrew T. Kicman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Psychopharmacology and Addiction.

In The Last Decade

Jim McVeigh

97 papers receiving 2.3k citations

Peers

Jim McVeigh
Paul Dillon Australia
Marie Claire Van Hout United Kingdom
Simona Zaami Italy
Andreas Kimergård United Kingdom
Kelly M. Smith United States
Jack Darkes United States
Charles E. Yesalis United States
Jennifer Schneider Australia
Siew Mooi Ching Malaysia
Dolly Baliunas Canada
Paul Dillon Australia
Jim McVeigh
Citations per year, relative to Jim McVeigh Jim McVeigh (= 1×) peers Paul Dillon

Countries citing papers authored by Jim McVeigh

Since Specialization
Citations

This map shows the geographic impact of Jim McVeigh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim McVeigh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim McVeigh more than expected).

Fields of papers citing papers by Jim McVeigh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jim McVeigh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim McVeigh. The network helps show where Jim McVeigh may publish in the future.

Co-authorship network of co-authors of Jim McVeigh

This figure shows the co-authorship network connecting the top 25 collaborators of Jim McVeigh. A scholar is included among the top collaborators of Jim McVeigh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim McVeigh. Jim McVeigh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kean, Joseph, John Campbell, Waljit S. Dhillo, et al.. (2023). The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men. Substance Abuse Treatment Prevention and Policy. 18(1). 66–66. 21 indexed citations
2.
Ven, Katinka van de, John M. Malouff, & Jim McVeigh. (2023). The Association Between the Nonmedical use of Anabolic–Androgenic Steroids and Interpersonal Violence: A Meta-Analysis. Trauma Violence & Abuse. 25(2). 1484–1495. 9 indexed citations
3.
Campbell, John, Paul Bassett, Suks Minhas, et al.. (2023). OR25-03 Self-administration Of Post-cycle Therapy Is Associated With Increased Probability Of Subsequent Normalisation Of Reproductive Hormones Following Anabolic-androgenic Steroid Cessation In Men. Journal of the Endocrine Society. 7(Supplement_1). 1 indexed citations
4.
Campbell, John, Paul Bassett, Ali Abbara, et al.. (2023). Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study. European Journal of Endocrinology. 189(6). 601–610. 9 indexed citations
5.
Hope, Vivian, Ian D. Boardley, Josie Smith, et al.. (2022). Anabolic androgenic steroid use population size estimation: a first stage study utilising a Delphi exercise. Drugs Education Prevention and Policy. 30(5). 461–473. 12 indexed citations
6.
Chegeni, Razieh, Ståle Pallesen, Jim McVeigh, & Dominic Sagoe. (2021). Anabolic-androgenic steroid administration increases self-reported aggression in healthy males: a systematic review and meta-analysis of experimental studies. Psychopharmacology. 238(7). 1911–1922. 30 indexed citations
7.
McVeigh, Jim, Evelyn Hearne, Ian D. Boardley, et al.. (2021). Generating evidence on the use of Image and performance enhancing drugs in the UK: results from a scoping review and expert consultation by the Anabolic Steroid UK network. Harm Reduction Journal. 18(1). 107–107. 17 indexed citations
8.
McCullough, Deaglan, Richard Webb, Kevin Enright, et al.. (2020). How the love of muscle can break a heart: Impact of anabolic androgenic steroids on skeletal muscle hypertrophy, metabolic and cardiovascular health. Reviews in Endocrine and Metabolic Disorders. 22(2). 389–405. 32 indexed citations
9.
Mulrooney, Kyle, Katinka van de Ven, Jim McVeigh, & Rick Collins. (2019). Steroid Madness- has the dark side of anabolic-androgenic steroids (AAS) been over-stated?. Performance Enhancement & Health. 6(3-4). 98–102. 24 indexed citations
10.
Bates, Geoff, et al.. (2019). Treatments for people who use anabolic androgenic steroids: a scoping review. Harm Reduction Journal. 16(1). 75–75. 39 indexed citations
11.
Hope, Vivian, Jim McVeigh, Josie Smith, et al.. (2017). Low levels of hepatitis C diagnosis and testing uptake among people who inject image and performance enhancing drugs in England and Wales, 2012-15. Drug and Alcohol Dependence. 179. 83–86. 16 indexed citations
12.
Simkhada, Padam, Bibha Simkhada, Harry Sumnall, et al.. (2016). Need and scope of global partnership on public health research. Journal of Datta Meghe Institute of Medical Sciences University. 11(3). 260–262.
13.
14.
Jones, Lisa, Amanda Atkinson, Geoff Bates, et al.. (2013). Views and experiences of hepatitis C testing and diagnosis among people who inject drugs: Systematic review of qualitative research. International Journal of Drug Policy. 25(2). 204–211. 41 indexed citations
15.
McVeigh, Jim, Michael Evans‐Brown, & Mark A Bellis. (2012). Drogas potenciadoras para la búsqueda de la perfección. Adicciones. 24(3). 185–185. 1 indexed citations
16.
Russell, Simon & Jim McVeigh. (2011). Next generation challenges: An overview of harm reduction 2010, IHRA's 21st conference. International Journal of Drug Policy. 22(1). 82–86. 1 indexed citations
17.
Jones, Lisa, Lucy Pickering, Harry Sumnall, Jim McVeigh, & Mark A Bellis. (2010). Optimal provision of needle and syringe programmes for injecting drug users: A systematic review. International Journal of Drug Policy. 21(5). 335–342. 56 indexed citations
18.
Evans‐Brown, Michael, Andreas Kimergård, & Jim McVeigh. (2009). Elephant in the room? The methodological implications for public health research of performance‐enhancing drugs derived from the illicit market. Drug Testing and Analysis. 1(7). 323–326. 26 indexed citations
19.
Beynon, Caryl, Jim McVeigh, Martin Chandler, Michelle Wareing, & Mark A Bellis. (2007). The impact of citrate introduction at UK syringe exchange programmes: a retrospective cohort study in Cheshire and Merseyside, UK. Harm Reduction Journal. 4(1). 21–21. 2 indexed citations
20.
Beynon, Caryl, Mark A Bellis, & Jim McVeigh. (2006). Trends in drop out, drug free discharge and rates of re-presentation: a retrospective cohort study of drug treatment clients in the North West of England. BMC Public Health. 6(1). 205–205. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Dillon Breakdown of academic impact, for papers by Marie Claire Van Hout Breakdown of academic impact, for papers by Simona Zaami Breakdown of academic impact, for papers by Andreas Kimergård Breakdown of academic impact, for papers by Kelly M. Smith Breakdown of academic impact, for papers by Jack Darkes Breakdown of academic impact, for papers by Charles E. Yesalis Breakdown of academic impact, for papers by Jennifer Schneider Breakdown of academic impact, for papers by Siew Mooi Ching Breakdown of academic impact, for papers by Dolly Baliunas
Rankless by CCL
2026